Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 4, 2025The Journal of Pathology

Small cell neuroendocrine carcinoma of the cervix: diagnostic challenges and emerging molecular insights †

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAlphonse CharbelSDSandeep DiwanSLShuk On Annie Leung

Discussion

Loading...

Member takes

Overview

Observational analysis emphasizes diagnostic challenges and potential immunotherapy in small cell neuroendocrine carcinoma, indicating a need for better biomarkers and algorithms.

Key Points

  • SCNECC showcases significant diagnostic challenges, often requiring advanced molecular testing for accurate identification.
  • Histopathological evaluation remains central, with diagnostic algorithms crucial for differentiating it from similar malignancies.
  • Integration of whole transcriptome profiling has identified molecular subgroups, some with potential susceptibility to immunotherapy.
  • Research indicates the necessity for improved biomarkers and comprehensive strategies to enhance treatment outcomes for this rare carcinoma.

Cite This Study

Charbel et al. (2025) studied this question.

synapsesocial.com/papers/6930dc78ea1aef094cca2236https://doi.org/10.1002/path.6486
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Complexities in differential diagnosis of poorly differentiated large cell neuroendocrine carcinoma of the cervix: a case report2025
  2. 2Clinical pathological analysis of primary small cell neuroendocrine carcinoma of the cervix: A retrospective study2025
  3. 3Integrative analysis of small cell carcinoma of the uterine cervix reveals its heterogeneity and provides novel predictive markers2026
  4. 4Small Cell Neuroendocrine Carcinoma of the Uterine Cervix: A Case Report Highlighting a Rare and Aggressive Tumor2025
  5. 5Clinicopathologic characteristics and prognostic outcomes of surgically treated neuroendocrine cervical carcinoma: A single institution retrospective analysis2025